Companies · 2026-11-07
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
#companies#moderna#vaccines
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Written with the help of AI by Ghostwriter KIERO SWISS from the sources named in the article. About the author and how we write

